CA
GMED icon

Cetera Advisors’s Globus Medical GMED Stock Holding History

Cetera Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$204K Buy
+3,807
New +$205K ﹤0.01% 2210

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Cetera Advisors's GMED Position: Q1 2024 in Review

Cetera Advisors opened a new position in Globus Medical (GMED) in Q1 2024: 3,807 shares worth $204K. The stake represents ﹤0.01% of the portfolio and ranks #2210 among its holdings.

439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Cetera Advisors held 3,807 shares of Globus Medical worth $204K as of Q1 2024.
  • Globus Medical was a new Cetera Advisors position in Q1 2024.
  • Globus Medical made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2210 holding.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.